Caseware UK (AP4) 2023.0.135 2023.0.135 2024-12-312024-12-31false2024-01-01trueNo description of principal activity00false 13130526 2024-01-01 2024-12-31 13130526 2023-01-01 2023-12-31 13130526 2024-12-31 13130526 2023-12-31 13130526 c:Director1 2024-01-01 2024-12-31 13130526 c:EntityHasNeverTraded 2024-01-01 2024-12-31 13130526 c:Micro-entities 2024-01-01 2024-12-31 13130526 c:AuditExempt-NoAccountantsReport 2024-01-01 2024-12-31 13130526 c:FullAccounts 2024-01-01 2024-12-31 13130526 c:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 13130526 d:PoundSterling 2024-01-01 2024-12-31 iso4217:GBP xbrli:pure

Registered number: 13130526










SPACICS LIMITED








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 DECEMBER 2024

 
SPACICS LIMITED
REGISTERED NUMBER: 13130526

BALANCE SHEET
AS AT 31 DECEMBER 2024

2024
2023
£
£


Called up share capital not paid
100
100

Total assets less current liabilities
100
100


Net assets
100
100



Capital and reserves
100
100


Notes


General information

SPACICS Limited is a private company limited by shares, which was incorporated in England.
The company did not trade during the period.


Average number of employees

The average monthly number of employees, including directors, during the year was 0 (2023 - 0).

The Company was entitled to exemption from audit under section 480 of the Companies Act 2006.

The members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared in accordance with the provisions applicable to entities subject to the micro-entities' regime.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 31 January 2025.




................................................
Robert Adam Gelling
Director

 
Page 1